Interaction of mithramycin and chromomycin A3 with d(TAGCTAGCTA)2:: Role of sugars in antibiotic-DNA recognition

被引:21
作者
Chakrabarti, S
Bhattacharyya, B
Dasgupta, D
机构
[1] Saha Inst Nucl Phys, Div Biophys, Kolkata 700037, India
[2] Bose Inst, Dept Biochem, Kolkata 700054, India
关键词
D O I
10.1021/jp014710i
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The anticancer antibiotics mithramycin (MTR) and chromomycin A(3) (CHR) inhibit macromolecular biosynthesis by binding reversibly to double-stranded DNA via the minor groove with GC base specificity in the presence of divalent cations such as Mg2+. They have different saccharide residues. Here, the role of the sugars in DNA recognition by the antibiotics has been investigated by use of a model oligomer, d(TAGCTAGCTA)(2), that contains two partially overlapping potential binding sites (GpC). Spectroscopic studies along with analysis of binding and thermodynamic parameters for the interaction(s) of the antibiotics with the oligomer illustrate that (MTR)(2)Mg2+ binds with a 2:1 stoichiometry in contrast to a 1:1 stoichiometry for (CHR)(2)Mg2+, in terms of ligand:duplex. Both associations are enthalpy-driven, the enthalpy change being higher in the case of (MTR)(2)Mg2+. Analysis of melting profiles of the oligomer in the absence and presence of the two ligands show that (MTR)(2)Mg2+ stabilizes the duplex. On the other hand, (CHR)(2)Mg2+ stabilizes only half of the oligomer,and destabilizes the other part. This is concluded from the appearance of two peaks in the differential melting curve, where the first peak is below the melting temperature of free oligomer and the second peak is above it. The experimental results lead to the following conclusions regarding the role of the sugars. The presence of substituents such as methoxy and acetoxy groups in the A, B, and E sugars of CHR reduces the flexibility of (CHR)(2)Mg2+ ligand. As a consequence, its association with the first binding site in the oligomer leads to partial unwinding and destabilization of the second, site. Hence, (CHR)(2)Mg2+ is unable to interact with both sites in the oligomer. In contrast, (MTR)(2)Mg2+ is more flexible. It undergoes conformational changes leading to 2:1 binding stoichiometry with the oligomer. Thus, the nature of substituents in the saccharides is a major factor leading to difference in DNA recognition properties of the antibiotics.
引用
收藏
页码:6947 / 6953
页数:7
相关论文
共 31 条
[1]   ROLE OF MG++ IN THE MITHRAMYCIN-DNA INTERACTION - EVIDENCE FOR 2 TYPES OF MITHRAMYCIN-MG++ COMPLEX [J].
AICH, P ;
DASGUPTA, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 173 (02) :689-696
[2]   INTERACTION BETWEEN ANTITUMOR ANTIBIOTIC CHROMOMYCIN A3 AND MG2+ .1. EVIDENCE FOR THE FORMATION OF 2 TYPES OF CHROMOMYCIN-A3-MG2+ COMPLEXES [J].
AICH, P ;
SEN, R ;
DASGUPTA, D .
CHEMICO-BIOLOGICAL INTERACTIONS, 1992, 83 (01) :23-33
[3]   ROLE OF MAGNESIUM-ION IN THE INTERACTION BETWEEN CHROMOMYCIN-A3 AND DNA - BINDING OF CHROMOMYCIN-A3-MG2+ COMPLEXES WITH DNA [J].
AICH, P ;
SEN, R ;
DASGUPTA, D .
BIOCHEMISTRY, 1992, 31 (11) :2988-2997
[4]   ROLE OF MAGNESIUM-ION IN MITHRAMYCIN DNA INTERACTION - BINDING OF MITHRAMYCIN MG2+ COMPLEXES WITH DNA [J].
AICH, P ;
DASGUPTA, D .
BIOCHEMISTRY, 1995, 34 (04) :1376-1385
[5]   NMR-STUDIES OF THE INTERACTION OF CHROMOMYCIN-A3 WITH SMALL DNA DUPLEXES - BINDING TO GC-CONTAINING SEQUENCES [J].
BANVILLE, DL ;
KENIRY, MA ;
KAM, M ;
SHAFER, RH .
BIOCHEMISTRY, 1990, 29 (27) :6521-6534
[6]   NMR INVESTIGATION OF MITHRAMYCIN-A BINDING TO D(ATGCAT)2 - A COMPARATIVE-STUDY WITH CHROMOMYCIN-A3 [J].
BANVILLE, DL ;
KENIRY, MA ;
SHAFER, RH .
BIOCHEMISTRY, 1990, 29 (39) :9294-9304
[7]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[8]  
CASTELLAN GW, 1989, PHYSICAL CHEM, P221
[9]  
Chabner B., 1996, GOODMAN GILMANS PHAR, P1233
[10]   Structure-based design fill of a new bisintercalating anthracycline antibiotic [J].
Chaires, JB ;
Leng, FF ;
Przewloka, T ;
Fokt, I ;
Ling, YH ;
PerezSoler, R ;
Priebe, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (03) :261-266